Table 2.
SLE – ICD n = 1,665 |
SLE – validated n = 71 |
ANA-associated rheumatic disease n = 1,644 | ANA+ Control n = 3,603 |
p-value a | |
---|---|---|---|---|---|
Age (years ± SD) | 50.5 ± 15.6 | 36.5 ± 15.2 | 50.5 ± 15.6 | 50.8 ± 18.3 | <0.001 |
Sex | |||||
Female Male |
1,491 (89.5%) 174 (10.5%) |
65 (91.5%) 6 (8.5%) |
1,445 (87.9%) 199 (12.1%) |
2,868 (79.6%) 735 (20.4%) |
<0.001 |
Race | |||||
White Black Other/Unknown |
1,092 (65.6%) 446 (26.8%) 127 (7.6%) |
44 (62.0%) 26 (36.6%) 1 (1.4%) |
1,330 (80.9%) 213 (13.0%) 101 (6.1%) |
2,848 (79.0%) 502 (13.9%) 253 (7.0%) |
<0.001 |
Ethnicity | |||||
Hispanic Non-Hispanic Unknown |
81 (4.9%) 1,472 (88.4%) 112 (6.7%) |
1 (1.4%) 69 (97.2%) 1 (1.4%) |
35 (2.1%) 1,467 (89.2%) 142 (8.6%) |
152 (4.2%) 3,169 (88.0%) 282 (7.8%) |
<0.001 |
Data are presented as mean ± SD or frequency (%) unless otherwise noted.
a p-value by ANOVA or chi-square test for continuous or categorical variables, respectively.